BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
2.216
+0.006 (0.27%)
At close: Oct 9, 2026, 4:00 PM EDT
2.250
+0.034 (1.53%)
After-hours: Oct 9, 2026, 7:37 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $11.7 million as of October 9, 2026. Its market cap has decreased by 36.22% in one year.
Market Cap
11.70M
Enterprise Value
9.48M
1-Year Change
-36.22%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 25, 2011, BioLineRx's market cap has decreased from $68.58M to $11.70M, a decrease of -82.94%. That is a compound annual growth rate of -10.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 11.70M | -10.70% |
| Dec 31, 2025 | 13.10M | -44.21% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 12.57M |
| GT Biopharma | 12.05M |
| Passage Bio | 11.87M |
| Intensity Therapeutics | 11.85M |
| Daré Bioscience | 11.82M |
| Pluri | 11.77M |
| Niki BioSolutions | 11.75M |
| Phio Pharmaceuticals | 11.37M |